| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |